Will Sarepta Therapeutics (SRPT) Report Negative Q4 Earnings? What You Should KnowZacks Investment Research • 02/17/21
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmNewsfile Corp • 02/08/21
Sarepta Therapeutics Announces Winners of the “Rare Lessons” Lesson Planning CompetitionGlobeNewsWire • 02/04/21
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmPRNewsWire • 02/01/21
Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing TherapeuticsGlobeNewsWire • 01/13/21
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 01/12/21
Sarepta Therapeutics, Inc. (SRPT) CEO Doug Ingram Presents at 39th Annual JPMorgan Virtual Healthcare Conference (Transcript)Seeking Alpha • 01/11/21
SRPT EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc.; Encourages Investors with Losses Exceeding $1 Million to Contact Firm - SRPTPRNewsWire • 01/09/21
SRPT INVESTIGATION ALERT: Bernstein Liebhard is Investigating Sarepta Therapeutics, Inc. For Violations of the Securities LawsPRNewsWire • 01/08/21
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the FirmBusiness Wire • 01/08/21
SRPT EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Sarepta Therapeutics, Inc. – SRPTBusiness Wire • 01/08/21
Sarepta Falls 50% To 10-Month Low After DMD Gene Therapy Study Misses Primary EndpointBenzinga • 01/08/21
Sarepta Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/08/21
Sarepta Crashes On Mixed Results For Gene Therapy In Muscular DystrophyInvestors Business Daily • 01/07/21